Oren Frank is a graduate from Leicester polytechnic who is very skilled in media, marketing, data, technology and strategy. He became a regional creative director EMEA at McCann Erikson from November 2001 to November 2003 based in London, UK, after which he was promoted to a CEO, world Group Israel at the same company based in Israel, telaviv from March 2003 to November 2007, simultaneously in the same company he was promoted to a Chairman position from November 2005 to November 2007.Oren Frank became a Global chief creative Officer at MRM worldwide from Jan 2008 to April 2011. Then worked as a writer, columnist, blogger at the markerAdge, Huffpo from march 2008 to February 2014. See more of Oren Frank at crunchbase
On April 2012 Oren Frank became the co-founder and CEO of TALKSPACE which is an online and mobile therapy company. The company has a number of independent consultable psychiatrists who give therapy lessons to company users online. The company hired a Chief Medical Officer, Neil Leibowitz. He is regarded as a major upgrade to TALKSPACE since the company is set to start prescribing medicines to its users when required. Oren Frank said that the company has hit one million users and is on the rise to increase more revenue.
The addition of Neil Leibowitz to the company makes Oren Frank hope for an approximate representation of a half of TALKSPACE revenues. This allows them to focus on mental health of employers and users since there is increased depression and anxiety which is a major hit among millennials.
A day ago TALKSPACE introduced itself to teens, where they use blogs and hashtags such as #talkspaceteens which gives a platform to parents and teens to ask fundamental questions about their health. Oren Frank is a skilled blogger reason why TALKSPACE is into blogging.
Read more: https://www.talkspace.com/blog/author/oren-frank/
A new health technology company from Chicago just received $80 million in funding to continue their work. The worth of Tempus is valued at over $1 billion. With the increase in funding the company has reached ‘Unicorn’ status. The Chicago market place uses the term for startup companies worth $1 billion. Tempus, founded by Eric Lefkofsky, uses data to research trends in cancer. With a growing employee base of over 400 people, Tempus works with partners throughout the healthcare system. The company gathers and analyzes the data of patients with cancer to provide helpful information doctors. Lefkofksy’s foundation website says that Tempus is, “a technology company that empowers doctors to personalize cancer treatment through data and analytics.”
Tempus specializes in cancer research and works with many partners in the medical field. They team up with doctors, patients and drug companies to gather information. Tempus uses data to do sequencing research on DNA and RNA. The leaders of Tempus hope this approach to the research will result in new information to help cancer patients. According to the Tempus website, “Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data.”
Tempus is not the first company Lefkofsky created. The entrepreneur co-founded the Lefkofsky Family Foundation, Groupon and Lightbank. The businessman graduated from the University of Michigan with a degree in law. Lefkofksky began working with startup companies that use technology to support their mission. He continues to teach at the University of Michigan as an adjunct professor.
Lefkofsky spends much of his time supporting other initiatives. He started the Lefkofsky Family Foundation with his wife to support education, arts, culture and human rights causes. According to the company website, “Its purpose is to advance high-impact initiatives that enhance the quality of human life in the communities we serve.”
To know more visit @: www.tempus.com/about-us/
Today we have more treatment options than ever before thanks to modern technology and science. Stem cells are one of the top treatment options for a number of conditions. Odds are, you’ve already heard about stem cells from one source or another. Most don’t read into it too much. Stem cells, however, are quite exceptional from other cells.
Stem cells are cells that have yet to form into a specific type of cell such as an organ or muscle and have the ability to replicate surrounding tissues. The Lung Institute uses stem cells to treat a variety of lung conditions such as:
Where Do the Stem Cells Come From?
- Chronic Bronchitis
- Pulmonary Fibrosis
- Interstitial Lung Disease
Stem cells can come from a variety of sources. The Lung Institute uses stem cells from the patient’s own body and is the leading provider in lung disease treatment. This is beneficial to the patient because the stem cells from one’s own body do not carry the risk of being rejected. How the stem cells are collected will depend on your condition and to what extent the condition has had on the lungs. A collection of stem cells through blood venous typically provides a sufficient quantity for conditions that are minor to moderate. Chronic conditions with moderate to severe damage may require more stem cells which will need to be collected from bone marrow as it contains more stem cells than the blood.
Why Stem Cell Therapy Different and How is it Performed?
There are traditional treatments for lung disease. The difference, however, is that traditional treatment options only treat the symptoms. Stem cell therapy can heal the lungs and even slow progression of the disease. Once the stem cells are collected, they will be separated from other cells and then placed back into the bloodstream. As the heart pumps blood throughout the body, the stem cells will be carried into the lung. Here they will become trapped and can begin replication of surrounding healthy tissues.
You can find The Lung Institute facilities through the nation in major cities. Regardless of location, you can expect experience and quality treatment through board-certified physicians and highly trained staff members. Whether your diagnose is new or something you’ve been struggling with for years, a free consultation can give you a better idea of your treatment options.
For more info, follow the Lung Institute on Twitter and subscribe to the Lung Institute’s YouTube channel.
Read More: https://www.cedars-sinai.edu/Patients/Programs-and-Services/Lung-Institute/